Plasma phospholipase A2 activity in patients with asthma: Association with body mass index and cholesterol concentration

Thorax

Volumn 63, Issue 1, 2008, Pages 21-26

  Misso, N L A ^a,b   Petrovic, N ^a   Grove, C ^a   Celenza, A ^a   Brooks Wildhaber, J ^a   Thompson, P J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLESTEROL; CORTICOSTEROID; PHOSPHOLIPASE A2; SECRETORY PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BLOOD SALVAGE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN TEST; STATISTICAL SIGNIFICANCE; ACUTE DISEASE; BLOOD; ENZYMOLOGY; MIDDLE AGED;

ACUTE DISEASE; ADULT; ASCORBIC ACID; ASTHMA; BODY MASS INDEX; CHOLESTEROL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPASES A2, SECRETORY;

EID: 38349124441     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.074112     Document Type: Article

References (41)

1. Dennis EA. Phospholipase A2 in eicosanoid generation. Am J Respir Crit Care Med 2000;161:S32-5.
2. Dennis EA. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997;22:1-2.
3. Balsinde J, Ralboa MA, Insel PA, et al. Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 1999;39:175-89.
4. Triggiani M, Granata F, Giannattasio G, et al. Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. J Allergy Clin Immunol 2005;116:1000-6.
5. Nevalainen TJ. Serum phospholipases A2 in inflammatory diseases. Clin Chem 1993;39:2453-9.
6. Lin MK, Farewell V, Vadas P, et al. Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. J Rheumatol 1996;23:1162-6.
7. Djukanovic R. Asthma: a disease of inflammation and repair. J Allergy Clin Immunol 2000;105:S522-6.
8. Blom M, Tool AT, Wever PC, et al. Human eosinophils express, relative to other circulating leukocytes, large amounts of secretory 14-kD phospholipase A2. Blood 1998;91:3037-43.
9. Perrin-Cocon L, Agaugue S, Coutant F, et al. Secretory phospholipase A2 induces dendritic cell maturation. Eur J Immunol 2004;34:2293-302.
10. Ramoner R, Putz T, Gander H, et al. Dendritic-cell activation by secretory phospholipase A2. Blood 2005;105:3583-7.
11. Tessier C, Hichami A, Khan NA. Implication of three isoforms of PLA(2) in human T-cell proliferation. FEBS Lett 2002;520:111-16.
12. Triggiani M, Granata F, Oriente A, et al. Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes. Eur J Immunol 2002;32:67-76.
13. Triggiani M, Granata F, Balestrieri B, et al. Secretory phospholipases A2 activate selective functions in human eosinophils. J Immunol 2003;170:3279-88.
14. Jo EJ, Lee HY, Lee YN, et al. Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappa B in human neutrophils. J Immunol 2004;173:6433-9.
15. Granata F, Petraroli A, Boilard E, et al. Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor. J Immunol 2005;174:464-74.
16. Kashima N, Nakajima H, Katsura T, et al. Study of serum phospholipase A2 activity in bronchial asthmatic patients. Arerugi 1993;42:723-7.
17. Mehta D, Gupta S, Gaur SN, et al. Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis 1990;142:157-61.
18. Stadel JM, Hoyle K, Naclerio RM, et al. Characterization of phospholipase A2 from human nasal lavage. Am J Respir Cell Mol Biol 1994;11:108-13.
19. Bowton DL, Seeds MC, Fasano MB, et al. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med 1997;155:421-5.
20. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med 2006;174:112-19.
21. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005;115:897-909.
22. Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000;8:605-19.
23. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 2000;87:349-54.
24. Pruzanski W, Stefanski E, de Beer FC, et al. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. J Lipid Pes 1998;39:2150-60.
25. Petrovic N, Grove C, Langton PE, et al. A simple assay for a human serum phospholipase A2 that is associated with high-density lipoproteins. J Lipid Res 2001;42:1706-13.
26. National Institutes of Health. National Asthma Education and Prevention Program Expert Panel Report II. Guidelines for the diagnosis and management of asthma. Bethesda: National Institutes of Health, 1997 NIH Publication No. 97-4051.
27. Touqui L, Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med 2001;1:739-54.
28. Kim YJ, Kim KP, Han SK, et al. Group V phospholipase A2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A2. J Biol Chem 2002;277:36479-88.
29. Balsinde J, Shinohara H, Lefkowitz LJ, et al. Group V phospholipase A(2)-dependent induction of cyclooxygenase-2 in macrophages. J Biol Chem 1999;274:25967-70.
30. Nakano T, Ohara O, Teraoka H, et al. Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 1990;265:12745-8.
31. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332:868-75.
32. Gronroos JM, Forsstrom JJ, Irjala K, et al. Phospholipase A2, C-reactive protein, and white blood cell count in the diagnosis of acute appendicitis. Clin Chem 1994;40:1757-60.
33. Kugiyama K, Ota Y, Takazoe K, et al. Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. Circulation 1999;100:1280-4.
34. Franklin PJ, Stick SM, Le Souef PN, et al. Measuring exhaled nitric oxide levels in adults: the importance of atopy and airway responsiveness. Chest 2004;126:1540-5.
35. Wouters EFM. The systemic face of airway diseases: the role of C-reactive protein. Eur Respir J 2006;27:877-9.
36. Bowton DL, Dmitrienko AA, Israel E, et al. Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma. J Asthma 2005;42:65-71.
37. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-19.
38. Sood A, Ford ES, Camargo CA Jr. Association between leptin and asthma in adults. Thorax 2006;61:300-5.
39. Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J Asthma 2003;40:733-9.
40. Olafsdottir IS, Gislason T, Thjodleifsson B, et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005;60:451-4.
41. Misso NL, Brooks-Wildhaber J, Ray S, et al. Plasma concentrations of dietary and nondietary antioxidants are low in severe asthma. Eur Respir J 2005;26:257-64.